Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for Refractory Small Intestinal Bleeding
NCT02707484Phase 3Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Apr 2016
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in gastrointestinal vascular malformation, sponsored by Shanghai Jiao Tong University School of Medicine. Started Apr 2016; status: completed.
02
Drugs
thalidomide
03
Conditions
gastrointestinal vascular malformation
Beyond the preview
Go deeper on NCT02707484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02707484.